These studies, together with the comparison of the expression of genes related to MHC-I molecules, granzyme B, etc., suggested that although the RCC in the high-risk group may infiltrate more immune cells, the antitumor immune function of these cells may be significantly limited. Here, GZMB is linked to renal cell carcinoma.